References
- Gehrau RC, Mas VR, Maluf DG. Hepatic disease biomarkers and liver transplantation: what is the potential utility of micrornas? Expert Rev Gastroenterol Hepatol. 2013;7(2):157–170.
- Chen X, Zhao Y, Wang F, Bei Y, Xiao J, Yang C. MicroRNAs in liver regeneration. Cell Physiol Biochem. 2015;37(2):615–628.
- Higgins GM, Anderson RM. Experimental pathology of the liver, I: restoration of the liver of the white rat following partial surgical removal. Arch Pathol. 1931;12:186–202.
- Demetris A, Kelly DM, Eghtesad B, et al. Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol. 2006;30(8):986–993.
- Du Z, Zhou Y, Lu X, et al. Octreotide prevents liver failure through upregulating 5’-methylthioadenosine in extended hepatectomized rats. Liver Int. 2016;36(2):212–222.
- Thomas K, Constantinos N, Konstantinos S, Ioanna C, Agathi P, Mata F. Insulin metabolism and assessment of hepatic insulin extraction during liver regeneration. A study in a rat model the authors report. J Investig Surg. 2019;33(1):69–76.
- Mori K, Ozawa K, Kiuchi T, et al. Insulinopenia as a risk factor in hepatectomy and its resolution by intraportal insulin administration. Am J Surg. 1991;162(1):43–49.
- Chu J, Sadler KC. New school in liver development: lessons from zebrafish. Hepatology 2009;50(5):1656–1663.
- Takebe T, Sekine K, Enomura M, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nat Protoc. 2014;9(2):396–484.